Insmed Inc (NASDAQ: INSM) kicked off on Tuesday, up 1.07% from the previous trading day, before settling in for the closing price of $77.63. Over the past 52 weeks, INSM has traded in a range of $21.92-$80.53.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 22.42%. While this was happening, its average annual earnings per share was recorded -0.40%. With a float of $174.62 million, this company’s outstanding shares have now reached $178.85 million.
Let’s determine the extent of company efficiency that accounts for 912 employees. In terms of profitability, gross margin is 76.51%, operating margin of -214.11%, and the pretax margin is -251.01%.
Insmed Inc (INSM) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Insmed Inc is 2.39%, while institutional ownership is 106.05%. The most recent insider transaction that took place on Jan 14 ’25, was worth 95,108. In this transaction Chief Medical Officer of this company sold 1,384 shares at a rate of $68.72, taking the stock ownership to the 100,165 shares. Before that another transaction happened on Jan 14 ’25, when Company’s Chief Operating Officer sold 1,457 for $68.72, making the entire transaction worth $100,125. This insider now owns 146,082 shares in total.
Insmed Inc (INSM) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.29 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -0.40% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.91% during the next five years compared to -4.82% drop over the previous five years of trading.
Insmed Inc (NASDAQ: INSM) Trading Performance Indicators
Take a look at Insmed Inc’s (INSM) current performance indicators. Last quarter, stock had a quick ratio of 5.99. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 40.93.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.56, a number that is poised to hit -1.16 in the next quarter and is forecasted to reach -4.33 in one year’s time.
Technical Analysis of Insmed Inc (INSM)
Looking closely at Insmed Inc (NASDAQ: INSM), its last 5-days average volume was 1.66 million, which is a drop from its year-to-date volume of 2.03 million. As of the previous 9 days, the stock’s Stochastic %D was 87.85%. Additionally, its Average True Range was 2.74.
During the past 100 days, Insmed Inc’s (INSM) raw stochastic average was set at 93.03%, which indicates a significant increase from 93.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 35.85% in the past 14 days, which was lower than the 38.66% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $72.07, while its 200-day Moving Average is $63.90. However, in the short run, Insmed Inc’s stock first resistance to watch stands at $79.44. Second resistance stands at $80.42. The third major resistance level sits at $81.60. If the price goes on to break the first support level at $77.28, it is likely to go to the next support level at $76.10. Now, if the price goes above the second support level, the third support stands at $75.12.
Insmed Inc (NASDAQ: INSM) Key Stats
The company with the Market Capitalisation of 14.04 billion has total of 178,903K Shares Outstanding. Its annual sales at the moment are 305,210 K in contrast with the sum of -749,570 K annual income. Company’s last quarter sales were recorded 93,430 K and last quarter income was -220,520 K.
